Viewing Study NCT00394225



Ignite Creation Date: 2024-05-05 @ 5:07 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00394225
Status: COMPLETED
Last Update Posted: 2006-10-31
First Post: 2006-10-30

Brief Title: Helium-Hyperoxia and 6MWT Distance in COPD
Sponsor: University of Saskatchewan
Organization: University of Saskatchewan

Study Overview

Official Title: The Effects of Helium-Hyperoxia on 6-Minute Walking Distance in Chronic Obstructive Pulmonary Disease - A Randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2006-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: We assessed the effect of altering inspired gas on the 6MWT distance in COPD We hypothesized that HeO2 would improve walking distance and reduce shortness of breath compared to both RA and O2 and potentially improve quality of life for COPD patients
Detailed Description: We hypothesized that inspiring helium-hyperoxia HeO2 would significantly improve 6-minute walking test 6MWT distance in Chronic Obstructive Pulmonary Disease COPD subjects

This was a blinded randomized crossover study At Visit 1 we assessed pulmonary function exercise capacity and 6MWT distance Visits 2 and 3 consisted of four 6MWT with different inspired gases room air by mask RA 100 O2 by mask Mask O2 100 O2 by nasal prongs Nasal O2 and 70 He30 O2 by mask HeO2 Walking distance shortness of breath leg fatigue O2 saturation and heart rate HR were assessed

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None